Evidence map›Paper›PMID 31901950›Full record

Observational studyDiabetologia2020

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).

Pablo Aschner, Juan J Gagliardino, Hasan Ilkova, Fernando Lavalle, Ambady Ramachandran, Jean Claude Mbanya, Marina Shestakova, Jean-Marc Chantelot, Juliana C N Chan

Erratum issued Registry-linked trialOpen access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04245267 (Effect of Multicomponent Integrated Care Intervention on the Metabolic Control and Quality of Life in Patients With Type 2 Diabetes), which is not on this map. Cited by 73 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 2 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04245267 naunknown statusnot on this map

Effect of Multicomponent Integrated Care Intervention on the Metabolic Control and Quality of Life in Patients With Type 2 Diabetes: the Mexico City DIAbetes EMPowerment and Improvement of Care Program

TypeinterventionalSponsorClinica Especializada en el Manejo de la Diabetes en la Ciudad de MexicoRan2017 to 2021Enrolled800ConditionsType 2 DiabetesArmsDIABEMPIC
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts' Opinion from the Gulf Region.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 10 countries.

Pablo AschnerJaveriana University School of Medicine, San Ignacio University Hospital, Carrera 7 # 40-62, Bogotá, 110231, Colombia. pabloaschner@gmail.com.ORCID https://orcid.org/0000-0002-6860-3620
Juan J GagliardinoCENEXA, Center of Experimental and Applied Endocrinology (La Plata National University National Scientific and Technical Research Council), La Plata, Argentina.
Hasan IlkovaDivision of Endocrinology Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Fernando LavalleFacultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Ambady RamachandranIndia Diabetes Research Foundation, Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Jean Claude MbanyaBiotechnology Center, Doctoral School of Life Sciences, Health and Environment, University of Yaounde I, Yaounde, Cameroon.
Marina ShestakovaEndocrinology Research Center, Moscow, Russia.
Jean-Marc ChantelotPrimary Care Medical China and Emerging Markets, Sanofi, Paris, France.
Juliana C N ChanDepartment of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
Chinese University of Hong Kong · HKEndocrinology Research Center · RUIndia Diabetes Research Foundation · INIstanbul University-Cerrahpaşa · TRPontificia Universidad Javeriana · COSanofi (France) · FRUniversidad Autónoma de Nuevo León · MXUniversidad Nacional de La Plata · ARUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisWe evaluated the secular trend of glycaemic control in individuals with type 2 diabetes in developing countries, where data are limited.

methodsThe International Diabetes Management Practices Study provides real-world evidence of patient profiles and diabetes care practices in developing countries in seven cross-sectional waves (2005-2017). At each wave, each physician collected data from ten consecutive participants with type 2 diabetes during a 2 week period. The primary objective of this analysis was to evaluate trends of glycaemic control over time.

resultsA total of 66,088 individuals with type 2 diabetes were recruited by 6099 physicians from 49 countries. The proportion of participants with HbA

conclusionsIn developing countries, glycaemic control in individuals with type 2 diabetes remained suboptimal over a 12 year period, indicating a need for system changes and better organisation of care to improve self-management and attainment of treatment goals.

Indexed as

Glycemic ControlAdultAgedBlood GlucoseCross-Sectional StudiesDeveloping CountriesDiabetes Mellitus, Type 2Drug MonitoringFemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedPatient Outcome AssessmentSelf-ManagementBlood GlucoseGlycated HemoglobinHypoglycemic AgentsClinical diabetesEducationEpidemiologyHealthcare deliveryInsulin therapyPrediction and prevention of type 2 diabetes

Identifiers

PMID31901950
PMCPMC7054372
OpenAlexW2998638642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.